Tirzepatide

What is Tirzepatide?

Tirzepatide is a new-generation incretin mimetic developed for the treatment of type 2 diabetes and has recently gained significant attention as an anti-obesity drug.

Its key feature is its dual action mechanism, mimicking two natural hormones:

• GLP-1 (Glucagon-like peptide-1): Helps suppress appetite and prolong satiety.

• GIP (Glucose-dependent insulinotropic polypeptide): Stimulates insulin secretion and boosts energy expenditure.

Mechanism of Action of Tirzepatide

• Appetite control: Reduces hunger, enabling people to eat less without discomfort.

• Delayed gastric emptying: Prolongs satiety and prevents post-meal blood sugar spikes.

• Increased energy expenditure: Stimulates the body to burn more calories.

• Balanced insulin and glucagon: Improves blood glucose regulation.

Effectiveness for Weight Loss

Clinical studies (SURMOUNT trials) have shown that:

• Patients using tirzepatide can lose on average 15–22% of their body weight within 72 weeks.

• Effectiveness is significantly greater than semaglutide (which averages about 10–15%).

• Approved by the FDA (U.S.) for use in patients with obesity and type 2 diabetes.

Who Is Tirzepatide For?

• Individuals resistant to weight loss despite lifestyle changes.

• Patients with type 2 diabetes, especially those with insulin resistance.

• People with visceral obesity (abdominal fat) or at risk of cardiovascular disease.

• Those who have tried other weight-loss methods without success.

Possible Side Effects

Like other GLP-1 agents, tirzepatide may cause:

• Nausea, vomiting

• Diarrhea or constipation

• Dizziness

• Excessive loss of appetite, especially at the beginning

Typically, these effects decrease with continued use. Physicians usually start with a low dose of 2.5 mg/week and gradually increase as tolerated.

Comparison: Semaglutide vs Tirzepatide vs Retatrutide

• Semaglutide: Primarily reduces appetite, moderate effectiveness, widely used, proven safety record.

• Tirzepatide: Stronger effect, more pronounced results, reduces appetite and boosts metabolism—suitable for people with higher body weight or difficulty losing weight.

• Retatrutide: The most powerful in this class so far, but not yet commercially available.

 If you want significant weight loss and must choose from what is currently available, Tirzepatide is a better option than Semaglutide.

Precautions

• Prescription-only medicine: Must be used under medical supervision.

• Contraindicated in patients with a history of thyroid C-cell tumors (MTC) or MEN2.

• Should not be self-administered without evaluation by healthcare professionals.

Conclusion

Tirzepatide is regarded as a “game changer” in the treatment of obesity and type 2 diabetes, offering more significant weight loss than previous drugs while also improving blood sugar control. However, safe and effective use requires close medical supervision.